AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CytoCore (Chicago) reported that it is launching a Phase I trial to begin this month for a "quick, accurate, inexpensive" screening test for endometrial and uterine cancers that it believes could change the lives of women with those cancers, or at risk for them, much the way Pap smears did for cervical cancer beginning in the 1960s.
The test, the InPath system, will rely on a specialized computer-guided image recognition microscope system and the new P2X7 genetic marker to identify precancerous cell changes.
"Some 40% of American women between the ages of 35 and 70 exhibit risk factors for endometrial or uterine cancer such as obesity, hypertension, diabetes or family history," said Steven Waggoner, MD, a gynecological oncologist and member of CytoCore's medical …
Source: HighBeam Research, CytoCore starts Phase I trial for uterine cancer testing.